National Center for Advancing Translational Sciences; Notice of Meeting, 72987 [2021-27911]

Download as PDF Federal Register / Vol. 86, No. 244 / Thursday, December 23, 2021 / Notices Part 3: Program Data Collection and Evaluation (Limit—3 Pages) Based on the required objectives, describe how the Tribe, Tribal organization, or UIO plans to collect data for the proposed project and activities. Identify any type(s) of evaluation(s) that will be used and how you will collaborate with partners (i.e., Tribal Epidemiology Center (TEC)) to complete any evaluation efforts or data collection. Funded projects are encouraged to coordinate data collection efforts with their TEC or Urban Epidemiology Center (for urban awardees) and should describe their plan for coordination and collaboration with the TEC. Part 4: Program Accomplishments Report (Limit—2 Pages) Describe the Tribe’s, Tribal organization’s, or UIO’s significant program activities and achievements/ accomplishments over the past 5 years associated with substance abuse prevention, treatment, and aftercare activities. Provide success stories, data, or other examples of how other funded projects/programs made an impact in your community to address substance abuse. If applicable, provide justification for lack of progress of previous efforts. Elizabeth A. Fowler, Acting Deputy Director, Indian Health Service. [FR Doc. 2021–27890 Filed 12–22–21; 8:45 am] BILLING CODE 4165–16–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jspears on DSK121TN23PROD with NOTICES1 National Center for Advancing Translational Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Center for Advancing Translational Sciences Advisory Council. This meeting is being held virtually only; there is no in-person option. The open sessions will be videocast and may be accessed by the public from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the VerDate Sep<11>2014 20:50 Dec 22, 2021 Jkt 256001 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: January 20–21, 2022. Closed: January 20, 2022, 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, Room 987/ 989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Open: January 20, 2022, 1:00 p.m. to 5:00 p.m. Agenda: Report from the Institute Director and other staff; view and discuss Clearance of Concepts. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, Room 987/ 989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Open: January 21, 2022, 1:00 p.m. to 5:00 p.m. Agenda: Program Updates; view and discuss Clearance of Concepts; NCATS Triennial Inclusions Report; Proposed Organizational Change: Division of Extramural Activities and Division of Rare Diseases Innovation. Place: National Center for Advancing Translational Sciences, National Institutes of Health, One Democracy Plaza, Room 987/ 989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 15 days after the meeting at NCATSCouncilInput@ mail.nih.gov. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 72987 Dated: December 20, 2021. David W Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–27911 Filed 12–22–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Board of Scientific Counselors, National Institute of Mental Health. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Mental Health, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, National Institute of Mental Health. Date: February 2–3, 2022. Time: February 2, 2022, 10:45 a.m. to 6:20 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892 (Virtual Meeting). Time: February 3, 2022, 11:00 a.m. to 6:20 p.m. Agenda: To review and evaluate personnel qualifications and performance, and competence of individual investigators. Place: Porter Neuroscience Research Center, Building 35A, 35 Convent Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jennifer E. Mehren, Ph.D., Scientific Advisor, Division of Intramural Research Programs, National Institute of Mental Health, NIH, 35A Convent Drive, Room GE 412, Bethesda, MD 20892–3747, 301–496–3501, mehrenj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: December 20, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–27862 Filed 12–22–21; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 86, Number 244 (Thursday, December 23, 2021)]
[Notices]
[Page 72987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27911]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Center for 
Advancing Translational Sciences Advisory Council.
    This meeting is being held virtually only; there is no in-person 
option. The open sessions will be videocast and may be accessed by the 
public from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: January 20-21, 2022.
    Closed: January 20, 2022, 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, Room 987/989, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Open: January 20, 2022, 1:00 p.m. to 5:00 p.m.
    Agenda: Report from the Institute Director and other staff; view 
and discuss Clearance of Concepts.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, Room 987/989, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Open: January 21, 2022, 1:00 p.m. to 5:00 p.m.
    Agenda: Program Updates; view and discuss Clearance of Concepts; 
NCATS Triennial Inclusions Report; Proposed Organizational Change: 
Division of Extramural Activities and Division of Rare Diseases 
Innovation.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, One Democracy Plaza, Room 987/989, 
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center for Advancing Translational Sciences, 1 
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice no later than 15 days after the meeting at 
[email protected]. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: December 20, 2021.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-27911 Filed 12-22-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.